Press release
Artificial Tears Market Size Report 2032: Trends, Growth Opportunities, and Forecast by DelveInsight
Artificial Tears Market
To read more about the latest highlights related to the Artificial Tears Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/artificial-tears-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Artificial Tears Market Report
• In May 2025, Grifols received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to begin a Phase 2 clinical trial of GRF312 Ophthalmic Solution, an immunoglobulin (IG) eye drop being developed as a potential new treatment for dry eye disease (DED).
• The artificial tears market was valued at USD 2,496.66 million in 2024, growing at a CAGR of 8.16% during the forecast period from 2025 to 2032 to reach USD 4,662.67 million by 2032.
• North America is projected to hold the largest share of the Artificial Tears market in 2024, driven by several key factors.
• The leading Artificial Tears Companies such as Alcon Inc., Johnson & Johnson Services, Inc., Sight Sciences, AbbVie Inc., Théa Laboratories, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aldeyra Therapeutics, Inc., Viatris Inc., Tarsus Pharmaceuticals, Inc., MiBo Medical Group, Horus Pharma, OASIS Medical, Inc., VISUfarma, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Novaliq GmbH, AFT Pharmaceuticals, NovaBay Pharmaceuticals, Inc., and others.
To know more about why North America is leading the market growth in the Artificial Tears Market, get a snapshot @ Artificial Tears Market Outlook- https://www.delveinsight.com/sample-request/artificial-tears-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Artificial Tears Market Dynamics
According to a recent study published in the Ocular Surface (2024), in 2024, over 344 million people worldwide were affected by Dry Eye Disease (DED), underscoring a significant and growing disease burden. This rising prevalence is fueling the global demand for effective treatment options. Artificial tears play a vital role in relieving symptoms by moisturizing the eyes and reducing irritation, thereby driving the market growth. According to the data from DelveInsight Analysis (2025) revealed that in 2023 alone, over 2.3 million males and 8.3 million females in Japan were diagnosed with DED. In the United Kingdom, the burden was similarly high, with approximately 2.8 million mild, 1.3 million moderate, and 2 million severe cases reported. Additionally, a 2023 study published in Nature estimated that around 400 million individuals in China suffered from DED, equating to roughly one to two out of every five people.
Artificial Tears Market Segmentation Analysis
Artificial Tears Market by Product Type (Cellulose Derived Tears, Glycerin Derived Tears, Polyethylene Glycol & Propylene Glycol-Based Tears, and Others), Formulation (Eye Drops, Eye Ointments, and Others), Application (Dry Eye Disease Treatment, Allergies & Infections, and Others), Distribution Channel (Hospital & Retail Pharmacies and Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
Get a sneak peek at the Artificial Tears Market Dynamics @ Artificial Tears Market Dynamics Analysis- https://www.delveinsight.com/sample-request/artificial-tears-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Artificial Tears Companies
Alcon Inc., Johnson & Johnson Services, Inc., Sight Sciences, AbbVie Inc., Théa Laboratories, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aldeyra Therapeutics, Inc., Viatris Inc., Tarsus Pharmaceuticals, Inc., MiBo Medical Group, Horus Pharma, OASIS Medical, Inc., VISUfarma, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Novaliq GmbH, AFT Pharmaceuticals, NovaBay Pharmaceuticals, Inc., and others.
Artificial Tears Market Drivers
The growing need for artificial tears is primarily driven by the rising global prevalence of the condition. A key contributing factor is the expanding geriatric population, which is more susceptible to developing dry eye symptoms due to age-related changes in tear production and ocular health. Additionally, increased product development and frequent new product launches among the leading market players are further supporting market momentum. These trends are creating a favorable environment for sustained growth, positioning the artificial tears market for robust and steady expansion from 2025 to 2032.
Which MedTech key players in the Artificial Tears Market are set to emerge as the trendsetter explore @ Artificial Tears Companies- https://www.delveinsight.com/sample-request/artificial-tears-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Artificial Tears Market Report
• Coverage- Global
• Forecast Period- 2025-2032
• Artificial Tears Companies- Alcon Inc., Johnson & Johnson Services, Inc., Sight Sciences, AbbVie Inc., Théa Laboratories, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aldeyra Therapeutics, Inc., Viatris Inc., Tarsus Pharmaceuticals, Inc., MiBo Medical Group, Horus Pharma, OASIS Medical, Inc., VISUfarma, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Novaliq GmbH, AFT Pharmaceuticals, NovaBay Pharmaceuticals, Inc., and others.
Interested in knowing the Artificial Tears Market by 2032? Click to get a snapshot of the Artificial Tears Market Trends- https://www.delveinsight.com/sample-request/artificial-tears-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Contents
1. Artificial Tears Market Report Introduction
2. Artificial Tears Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Artificial Tears Market Key Factors Analysis
6. Artificial Tears Market Porter's Five Forces Analysis
7. Artificial Tears Market Assessment
8. Artificial Tears Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Tears Market Size Report 2032: Trends, Growth Opportunities, and Forecast by DelveInsight here
News-ID: 4213922 • Views: …
More Releases from DelveInsight Business Research LLP
Small Cell Lung Cancer Market Projected to Expand by 2034 | Ipsen Biopharmaceuti …
The Small Cell Lung Cancer (SCLC) market is anticipated to grow due to factors such as increasing disease prevalence, rising investments in research and development, and the introduction of new therapies over the forecast period from 2020 to 2034.
The market report provides a comprehensive overview of SCLC, including market size and share, epidemiology, emerging treatment options, key drivers and challenges, ongoing clinical trials, notable collaborations, and therapy adoption by leading…
Chronic Hand Eczema Market Projected to Grow by 2034 | LEO Pharma, Japan Tobacco …
The growth of the chronic hand eczema market is fueled by rising disease prevalence, increased research and development investments, and the introduction of new therapies during the forecast period from 2020 to 2034.
The market report provides detailed insights into chronic hand eczema, including market size, share, epidemiology, emerging treatments, key drivers and challenges, ongoing clinical trials, strategic collaborations, and the adoption of therapies by leading companies actively contributing to market…
Adult-onset Still Disease (AOSD) Market Projected to Grow by 2034 | Cerecor, Roc …
The growth of the Adult-onset Still Disease market is fueled by factors such as rising disease prevalence, increased investment in research and development, and the introduction of innovative therapies during the forecast period from 2020 to 2034.
The market report provides detailed insights into AOSD, including market size and share, epidemiology, emerging treatment options, key drivers and challenges, ongoing clinical trials, strategic collaborations, and therapy adoption by leading companies actively contributing…
Ovarian Cancer Pipeline Drugs Report 2025: Innovative Drug Developments and Ongo …
DelveInsight's "Ovarian Cancer Pipeline Insight 2025" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Ovarian Cancer pipeline landscape. It covers the Ovarian Cancer Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Ovarian Cancer Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious about the latest updates in…
More Releases for Tears
Evolving Market Trends In The Artificial Tears Industry: Innovative Advances In …
The Artificial Tears Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Artificial Tears Market Size During the Forecast Period?
The market size for artificial tears has experienced solid growth in the past few years, with predictions that it will increase from $3.55…
Artificial Tears Demand Soars As Dry Eye Disease Prevalence Increases: A Key Fac …
"What Are the Projections for the Size and Growth Rate of the Artificial Tears Market?
The artificial tears market has demonstrated strong growth in recent years. It is projected to rise from $3.55 billion in 2024 to $3.78 billion in 2025, with a CAGR of 6.5%. The past expansion was driven by an aging population, increased screen time, higher healthcare expenditures, a shift from prescription to OTC products, and regulatory changes.
The…
Artificial Tears Market Future Prediction Report By 2031
The Artificial Tears Market business intelligence report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation.
Get PDF Sample Report + All Related Table and Graphs @: https://www.theinsightpartners.com/sample/TIPRE00004073/?utm_source=OpenPR&utm_medium=10852
The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political…
Artificial Tears Market - Revitalize Your Eyes, Reawaken Your Gaze: Trust Artifi …
Newark, New Castle, USA: The "Artificial Tears Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Artificial Tears Market: https://www.growthplusreports.com/report/artificial-tears-market/7961
This latest report researches the industry structure, sales, revenue,…
Artificial Tears Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Artificial Tears Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
Artificial tears are lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.
Global Artificial Tear Production Volume Increased From…
Preventing and Repairing Rotator Cuff Tears
Rotator cuff tears are a common cause of shoulder pain. The most common type of rotator cuff tear involves failure of the tendon to attach to the tuberosity. This usually occurs near the bicep tendon, or the supraspinatus tendon.
Pain resulting from a rotator cuff tear can be felt over the outside of the shoulder and upper arm. Patients may find it difficult to raise the injured arm above the…
